What is ADMA Biologics's PP&E (net)?

ADMA Biologics (ADMA) reported PP&E (net) of $65.01M in Q1 2026.

How has ADMA Biologics's PP&E (net) changed year-over-year?

ADMA Biologics's PP&E (net) increased by 12.6% year-over-year, from $57.71M to $65.01M.

What is the long-term trend for ADMA Biologics's PP&E (net)?

Over 5 years (2020 to 2025), ADMA Biologics's PP&E (net) has grown at a 9.4% compound annual growth rate (CAGR), from $41.59M to $65.06M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

ADMA Biologics ADMA PP&E (Net)

PP&E (Net) at other companies

AnaptysBio, Inc.ANAB

$1.28M-26.5%

ZymeworksZYME

$14.85M-11.0%

Bio-Rad LaboratoriesBIO

$527.5M-0.2%

Apogee Therapeutics, Inc.APGE

$5.28M-7.0%

Quest DiagnosticsDGX

$2.19B+4.3%

BiohavenBHVN

$15.26M-14.2%

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's PP&E (net)?: ADMA Biologics (ADMA) reported PP&E (net) of $65.01M in Q1 2026.
How has ADMA Biologics's PP&E (net) changed year-over-year?: ADMA Biologics's PP&E (net) increased by 12.6% year-over-year, from $57.71M to $65.01M.
What is the long-term trend for ADMA Biologics's PP&E (net)?: Over 5 years (2020 to 2025), ADMA Biologics's PP&E (net) has grown at a 9.4% compound annual growth rate (CAGR), from $41.59M to $65.06M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.